Compounds > fenofibrate
Page last updated: 2024-10-27

fenofibrate and Bone Loss, Perimenopausal

fenofibrate has been researched along with Bone Loss, Perimenopausal in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samadfam, R1
Awori, M1
Bénardeau, A1
Bauss, F1
Sebokova, E1
Wright, M1
Smith, SY1

Other Studies

1 other study available for fenofibrate and Bone Loss, Perimenopausal

ArticleYear
Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
    The Journal of endocrinology, 2012, Volume: 212, Issue:2

    Topics: Adiposity; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone

2012